DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Misonidazole is an investigational drug.
There have been 14 clinical trials for Misonidazole. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2009.
The most common disease conditions in clinical trials are Lung Neoplasms, Glioblastoma, and Hypoxia. The leading clinical trial sponsors are National Cancer Institute (NCI), Proacta, Incorporated, and OHSU Knight Cancer Institute.
Recent Clinical Trials for Misonidazole
|Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma||William Rhodes Center for Glioblastoma||Phase 1|
|Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma||Weill Medical College of Cornell University||Phase 1|
|Feasibility of FMISO in Brain Tumors||National Cancer Institute (NCI)||Phase 2|